Monopar Therapeutics - Common Stock, par value $0.001 per share (MNPR)

Historical Holders from Q3 2024 to Q3 2025

Symbol
MNPR on Nasdaq
CUSIP
61023L207
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
7.5M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
4.34M
Holdings value
$354M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
54
Number of buys
32
Number of sells
-18
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Monopar Therapeutics - Common Stock, par value $0.001 per share (MNPR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 19.5% +1.58% $105M $9.39M 1.29M +9.81% JANUS HENDERSON GROUP PLC Sep 30, 2025
RA CAPITAL MANAGEMENT, L.P. 9.9% 0% $60.6M $10M 743K +19.8% RA Capital Management, L.P. Sep 30, 2025
Monopar Therapeutics 13.4% $24.6M 705K Hendricks Diane Dec 9, 2024
Adage Capital Management, L.P. 9.86% $20.9M 599K Adage Capital Management, L.P. Dec 31, 2024
Tactic Pharma LLC 7.5% $18.3M 506K Robinson Chandler Sep 24, 2025

Institutional Holders of Monopar Therapeutics - Common Stock, par value $0.001 per share (MNPR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 4.34M $354M +$99.8M $81.67 54
2025 Q2 3.18M $113M +$10.3M $35.78 43
2025 Q1 2.89M $109M +$11.5M $36.41 34
2024 Q4 2.58M $57.1M +$56.8M $22.00 18
2024 Q3 15.7K $106K +$106K $6.74 6